News
About gadoquatrane Gadoquatrane is Bayer’s investigational extracellular macrocyclic contrast agent in clinical development for contrast enhancement in MRI.
Digital holographic microscopy (DHM), an interferometric technology, is one of the commonly used methods for non-destructive phase imaging.
The Phase I trial assessed the safety profile of GE Healthcare’s injectable manganese MRI contrast agent in healthy volunteers.
Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well ...
PUEBLO, Colo. (KRDO) - For the fourth phase of the highly anticipated expansion of the Historic Arkansas Riverwalk, the majority of water has been drained. The river channel in the heart of Pueblo ...
Washington Free Beacon Editor Peter J Hasson warns Vice President Kamala Harris will be under a “microscope” as she looks to become the Democrat nominee.
All the latest science news on phase contrast microscopy from Phys.org. Find the latest news, advancements, and breakthroughs.
Aquyre Biosciences, Inc. today announced the appointment of Gregory Bowles as President, Chief Executive Officer and member of the Board of Directors.
Fig. 3 shows FRET and microscopy data for all symmetric and asymmetric compositions plotted in a leaflet–leaflet phase diagram. The horizontal and vertical axes quantify the fraction of DPPC in the ...
Small-airway obstruction, which cannot be seen with conventional X-rays, was observed in a virtual chest X-ray enhanced by phase-contrast imaging, according to study results published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results